Bristol-Myers Squibb
BMY
#187
Rank
A$172.82 B
Marketcap
A$84.61
Share price
-0.77%
Change (1 day)
22.60%
Change (1 year)

Bristol-Myers Squibb (BMY) - Cash on Hand

Cash on Hand as of June 2026 : A$15.83 Billion

According to Bristol-Myers Squibb's latest financial reports the company has A$15.83 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Bristol-Myers Squibb - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$15.93 B-8.73%
2024-12-31A$17.45 B-3.14%
2023-12-31A$18.02 B32.56%
2022-12-31A$13.59 B-42.76%
2021-12-31A$23.75 B11.03%
2020-12-31A$21.39 B-2.69%
2019-12-31A$21.98 B76.83%
2018-12-31A$12.43 B42.5%
2017-12-31A$8.72 B-0.95%
2016-12-31A$8.80 B50.29%
2015-12-31A$5.86 B-35.48%
2014-12-31A$9.08 B79.08%
2013-12-31A$5.07 B86.35%
2012-12-31A$2.72 B-68.04%
2011-12-31A$8.51 B18.5%
2010-12-31A$7.18 B-24.16%
2009-12-31A$9.47 B-19.1%
2008-12-31A$11.71 B360.32%
2007-12-31A$2.54 B-50.01%
2006-12-31A$5.09 B-35.77%
2005-12-31A$7.92 B-17.94%
2004-12-31A$9.65 B29.07%
2003-12-31A$7.48 B5.69%
2002-12-31A$7.08 B-36.09%
2001-12-31A$11.07 B82.99%
2000-12-31A$6.05 B34.54%
1999-12-31A$4.49 B22.79%
1998-12-31A$3.66 B63.99%
1997-12-31A$2.23 B5.61%
1996-12-31A$2.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$29.70 B 87.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.00 B-30.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.74 B 5.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.40 B-40.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$12.80 B-19.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.01 B 26.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.37 B-34.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$1.83 B-88.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.21 B-35.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.10 B-55.11%๐Ÿ‡ฌ๐Ÿ‡ง UK